Anavex Life Sciences Corp (NASDAQ:AVXL)

2.75
Delayed Data
As of Aug 19
 +0.04 / +1.48%
Today’s Change
1.25
Today|||52-Week Range
4.09
+76.28%
Year-to-Date
No recent news for Anavex Life Sciences Corp.

Today’s Trading

Previous close2.71
Today’s open2.74
Day’s range2.61 - 2.83
Volume216,401
Average volume (3 months)478,834
Market cap$141.1M
Data as of 4:00pm ET, 08/19/2019

Growth & Valuation

Earnings growth (last year)-18.42%
Earnings growth (this year)-58.97%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.01

Competitors

 Today’s
change
Today’s
% change
BCLIBrainstorm Cell Ther...+0.10+2.76%
XCURExicure Inc-0.10-3.66%
ORGSOrgenesis Inc+0.04+0.89%
CLXTCalyxt Inc+0.22+3.24%
Data as of 3:59pm ET, 08/19/2019

Financials

Next reporting dateDecember 9, 2019
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$17.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Director
Christopher U. Missling
Senior Vice President-
Operations
Stephan Toutain
Corporate headquarters
New York, New York

Forecasts